Western Equine Encephalitis Virus

Pathological Mechanisms

Following a mosquito bite, initial viral replication occurs in skeletal muscle and connective tissue, causing a primary viremia. The virus then seeds secondary lymphoid tissues, leading to a secondary, higher-titer viremia that may breach the blood-brain barrier (BBB). The exact mechanism of BBB penetration is unclear but may involve infection of the vascular endothelium or transport via infected immune cells. Within the CNS, WEEV predominantly infects neurons, leading to neuronal necrosis, inflammation (perivascular cuffing, gliosis), and edema, particularly affecting the basal ganglia, thalamus, and brainstem.

Transmission Cycle

WEEV is maintained in an enzootic cycle involving passerine birds (primary reservoir hosts) and ornithophilic mosquitoes. The primary enzootic vector in western North America is Culex tarsalis, a highly competent mosquito species adapted to agricultural and rural environments.

• Enzootic (Bird-Mosquito) Cycle: Wild birds, particularly songbirds, experience high-titer viremia sufficient to infect feeding mosquitoes without severe illness. Cx. tarsalis mosquitoes transmit the virus among avian populations.
• Epizootic/Dead-end Spillover: When conditions favor high mosquito populations and viral amplification, "bridge vectors" (e.g., Aedes spp., Culiseta melanura in some regions) or Cx. tarsalis itself may feed on and transmit the virus to dead-end hosts like horses and humans. These hosts do not develop sufficient viremia to perpetuate the transmission cycle.

Pathogenesis and Clinical Presentation

Human Disease

The majority of human WEEV infections (approximately 99% of adults, 1 in 58 children) are asymptomatic or result in a mild, non-specific febrile illness. For those who develop neuroinvasive disease, the incubation period is typically 2-10 days.

• Systemic Phase: Initial symptoms include sudden onset of fever, headache, nausea, vomiting, and malaise.
• Neurological Phase (Encephalitis): A subset of patients, particularly infants and older adults, may progress to severe central nervous system (CNS) involvement within 1-4 days. Signs include lethargy, irritability, photophobia, neck stiffness, confusion, seizures, and focal neurological deficits. Coma and death can follow.

Equine Disease

Horses are highly susceptible and serve as a key sentinel for human risk. The disease in horses is often acute and severe. Symptoms include high fever, depression, anorexia, and profound neurological signs: ataxia, circling, head pressing, inability to swallow, paralysis, and death. The case fatality rate in unvaccinated horses can reach 20-50%.

Conclusions

Western Equine Encephalitis Virus represents a classic and historically important New World arbovirus. Its dramatic decline in incidence is a public health success story, yet its persistence in nature underscores its potential as a re-emerging threat. A thorough understanding of its virology, intricate enzootic cycle, and clinical impact remains vital for clinicians, veterinarians, and public health officials. Continued investment in equine vaccination, vector surveillance, and ecological research is paramount to ensure that the large-scale epidemics of the past remain a historical footnote and not a future reality. WEEV serves as a persistent reminder of the delicate balance within ecosystems that governs the threat of vector-borne diseases.